Icahn Enterprises L.P. Q3 2026 Earnings Webcast - ICAHN ENTERPRISES LP

Explicit Guidance:

• No formal numerical financial guidance (e.g., revenue, earnings, or margin ranges) provided for FY2026 or future periods; forward-looking commentary focuses on qualitative expectations rather than specific metric targets.

Business-Segment Outlook:

• Energy (CVR): Assets expected to generate "substantial cash flow over the next 12 months and beyond" driven by the transformative acquisition of two refineries and a marketing platform; positioned to benefit from "global tightness in refined product and nitrogen fertilizer."
• Fertilizer: Facilities back online post-ECW turnaround, positioned to capitalize on "tight nitrogen supplies and the fall ammonia application season."
• Automotive: Post-sale of Pep Boys, retained business (royalty/franchising) expected to remain "flat" relative to prior quarter; Real Estate segment expected to see improved cash flows and results as "vacant space continues to lease up."
• Pharma: "Transcend trial preparation for our PAH drug remains on schedule" with four active sites and patient screening underway.
• Investment Funds: Strategy to increase liquidity and trading volume of CVI shares via secondary equity transaction; IEP expects its $500M backstop commitment to be reduced dollar-for-dollar and unlikely to be needed.

Market and Competitive Outlook:

• Refining environment described as "current favorable," with CVR citing "record crack spreads in the mid-con" driving record earnings.
• Nitrogen fertilizer market anticipated to remain tight, supporting pricing and demand for CVR's output.
• Hospitality sector demand described as "softening," and supply chain disruptions in the "Strait of Hormuz" remain a continued factor for Home Fashions.

Macro / Industry Outlook:

• Management notes "general tightness in global refined product and nitrogen fertilizer" as a structural driver for future segment performance.
• No specific commentary on interest rates, FX, or broad macroeconomic indicators beyond implicit references to "favorable" market conditions and supply constraints.

Strategic Initiatives:

• M&A: CVI executed a $4.2B acquisition of two refineries and a marketing platform at <3.5x 2026 EBITDA estimate; pro forma impact projected to increase CVR's EBITDA by >$1B and EPS by >105% for the nine months ended Sept 30, 2026.
• Capital Allocation: CVR declared a new 10-cent dividend; IFF authorized a $2.5B share repurchase program; IEP intends to address senior notes maturing May 2027 (callable Nov 15) in "coming months" using available liquidity.
• Asset Optimization: Continued execution on leasing up vacant space assumed in the Real Estate segment following the Pep Boys sale.

Risks and Headwinds to Outlook:

• Hedging: Refining hedges within funds contributed to a significant negative return (-31.3% including hedges vs -5.5% excluding), creating volatility in NAV.
• Regulatory/Operational: Future fertilizer results dependent on facility operational continuity (post-ECW turnaround).
• Market Competition: Pharma segment facing "generic competition" in anti-obesity drug therapy, driving reduced sales.
• Supply Chain: Ongoing disruptions in the Strait of Hormuz impacting Home Fashions.
• Execution Risk: Projections regarding the accretive nature of the CVI acquisition and future cash flow generation rely on maintaining current "favorable" market conditions.

Management Tone on the Future:

• Confidence: High confidence in the CVI acquisition, described as "highly accretive" and adding "strong cash generating assets at an attractive valuation"; confident in CVI's ability to benefit from global supply tightness.
• Flexibility: Strong tone regarding liquidity ("significant flexibility") to address debt maturity or capitalize on new opportunities.
• Cautions: Moderate caution regarding near-term volatility in investment fund NAVs due to refining hedge losses and external market factors.

Miscellaneous:

• Legal/Safe Harbor: Standard forward-looking statement disclaimer regarding risks, uncertainties, and the inability to update statements except as required by law.
• Non-GAAP: Acknowledgement that results include non-GAAP measures (Adjusted EBITDA) and indicative net asset value (NAV) which include fair value changes not in GAAP earnings.